Kimia Medisinal dan Masa Depan Pengobatan
DOI:
https://doi.org/10.55606/klinik.v4i2.3989Keywords:
medicinal chemistry, drug development, personalized medicine, artificial intelligence, nanotechnologyAbstract
This study aims to review the latest developments in medicinal chemistry and its prospects in the development of future treatments. Through a comprehensive literature study approach, this study analyzes the latest innovations in drug design and development, including the use of computational technology, nanotechnology, and biological target-based approaches. The results show that the integration of artificial intelligence and machine learning technologies with conventional medicinal chemistry techniques has opened a new paradigm in more efficient and precise drug discovery. Personalization of treatment based on patient genetic profiles, development of new antibiotics to overcome antimicrobial resistance, and nanomaterial-based therapies are important trends in contemporary medicinal chemistry applications. This study concludes that the future of medicine will be greatly influenced by advances in medicinal chemistry, with the main challenges being safety, regulation, and accessibility.More intensive multidisciplinary collaboration is needed between chemists, biologists, pharmacologists, clinical medicine, and informatics to optimize the potential of medicinal chemistry in the future medicine revolution.
References
Amin Saeful, dan Dian Eka Pratama. (2025). Peran Kimia Medinsial dalam Pengembangan Obat Anti Kangker: Pendekatan Komputasi dan Eksplorasi Senyawa Bioaktif dari Sumber Alam. Jurnal Indonsesia of Sciense. 1(6). 1356-1361.
Amin Saeful, dkk. (2025). Pendekatan Kimia Medisinal dalam Penemuan Senyawa Antiretroviral Baru: Integrasi Komputasi dan Perspektif Klinis di Era Resistensi HIV. 5(2). Journal of Creative and Inovatif. Hal 256-263.
Anastas, P. T., & Zimmerman, J. B. (2021). The molecular basis of sustainability in chemical innovation. Chemical Society Reviews, 50(15), 8423-8446.
Arrahman, A., & Sutrisno, B. (2023). Pemanfaatan kecerdasan buatan dalam pengembangan obat berbasis struktur: Tinjauan sistematis kemajuan satu dekade terakhir. Jurnal Farmasi Indonesia, 19(2), 134-152.
Badan POM RI. (2023). Laporan tahunan pengawasan obat dan makanan 2022: Fokus pada inovasi dan kemandirian. Jakarta: BPOM RI
Chen, H., & Qiao, Z. (2022). AI-powered virtual screening for drug discovery: Progress and challenges. Journal of Medicinal Chemistry, 65(8), 6245-6263.
Darwis, D., Maharani, R., & Pratiwi, R. (2022). Integrasi etnofarmakologi dan pendekatan berbasis komputasi dalam pemanfaatan tumbuhan obat Indonesia: Prospek dan tantangan. Jurnal Bahan Alam Indonesia, 21(1), 45-63.
Davies, J., & Davies, D. (2020). Origins and evolution of antibiotic resistance. Microbiology and Molecular Biology Reviews, 84(3), e00002-20.
Erlanson, D. A., Davis, B. J., & Jahnke, W. (2020). Fragment-based drug discovery: Advancing fragments in the absence of crystal structures. Cell Chemical Biology, 27(9), 1124- 1135.
Farokhzad, O. C., & Langer, R. (2022). Impact of nanotechnology on drug delivery. ACS Nano, 16(4), 5021-5035.
Gunawan, S., & Handayani, S. (2024). Perkembangan terapi berbasis oligonukleotida dalam pengobatan penyakit genetik: Peluang implementasi di negara berkembang. Indonesian Journal of Pharmaceutical Sciences, 12(1), 17-36.
Hadinegoro, S. R., & Sutrisna, B. (2023). Health economics considerations in drug development in developing countries: Indonesian perspective. Indonesian Journal of Pharmaceutical Sciences, 21(2), 145-159.
Harahap, Y., & Wibowo, A. E. (2024). Multi-omics integration for precision medicine: Current status and future directions in Indonesia. Genomics Indonesia, 9(1), 1-15.
Harahap, Y., Sulistiawati, E., & Purwanto, D. J. (2021). Development and characterization of antibody-conjugated solid lipid nanoparticles for targeted delivery of doxorubicin to breast cancer cells. International Journal of Nanomedicine, 16, 2345-2358.
Harrer, S., Shah, P., Antony, B., & Hu, J. (2022). Artificial intelligence for clinical trial design. Trends in Pharmacological Sciences, 43(2), 118-133.
Hasanah, M., & Wijaya, D. (2024). Pengembangan inhibitor kinase selektif berbasis komputasi: Strategi dan aplikasi dalam terapi kanker presisi. Jurnal Kedokteran dan Kesehatan Indonesia, 15(1), 83-97.
Hasanudin, M., & Wijaya, D. (2022). Interaksi obat-mikrobiota dalam modulasi efek farmakologis: Implikasi untuk pengembangan terapi presisi. Jurnal Mikrobiologi Indonesia, 16(3), 145-158.
Hessler, G., & Bajorath, J. (2023). Artificial intelligence in drug discovery.
Jauhari, A., & Permana, S. (2023). Dilema etika dan hukum dalam pemanfaatan data genomik untuk riset farmakogenetik di Indonesia. Jurnal Etika Biomedis, 7(2), 89-104.
Kurniawan, F., & Purnomo, H. (2023). Pemanfaatan teknologi organ-on-chip dalam evaluasi toksisitas obat: Kemajuan dan prospek aplikasi di Indonesia. Indonesian Journal of Pharmacy Science and Technology, 10(2), 167-184.
Kusuma, I., Santoso, B., & Widyastuti, P. (2023). Nanoteknologi dalam sistem penghantaran obat: Kemajuan terkini dan aplikasi klinis. Jurnal Sains Farmasi & Klinis, 10(2), 78-92.
Malik, A., & Rachman, F. (2022). Drug repurposing sebagai strategi akselerasi penemuan terapi baru: Pembelajaran dari pandemi COVID-19. Indonesian Journal of Medicinal Chemistry, 14(3), 189-205.
Mulyani, E., & Hadinata, F. (2023). Fragment-based drug design dalam pengembangan inhibitor enzim: Prinsip, metodologi, dan aplikasi. Makara Journal of Science, 27(1), 12-28.
Pratama, M. R., & Nugroho, A. E. (2024). Integrasi multi-omics dalam identifikasi biomarker dan target terapi potensial: Perkembangan terkini dan prospek masa depan. Jurnal Farmasi Klinik Indonesia, 13(1), 56-74.
Purwanti, L., & Wijayanto, H. (2022). Penerapan green chemistry dalam sintesis senyawa bioaktif: Menuju pengembangan obat berkelanjutan. Jurnal Kimia dan Pendidikan Kimia, 7(3), 221-237.
Rahmawati, N., & Widodo, T. (2022). Bioinformatika struktural dalam desain dan pengembangan antivirus: Tinjauan kemajuan dan tantangan. Jurnal Bioteknologi dan Biosains Indonesia, 9(3), 241-259.
Robertson, M. N., Ylioja, P. M., Williamson, A. E., et al. (2021). Open source drug discovery: Highly potent antimalarial compounds derived from the Tres Cantos arylpyrroles. ACS Central Science, 7(3), 467-475.
Setiabudy, R., & Nasution, A. K. (2023). Farmakogenomik dalam optimasi terapi: Implementasi dan tantangan dalam sistem kesehatan Indonesia. Indonesian Journal of Clinical Pharmacy, 12(4), 312-330.
Sudarman, A., & Rusli, R. (2022). Aktivitas antimalaria dari derivat kurkumin terhadap strain Plasmodium falciparum resisten artemisinin. Jurnal Kefarmasian Indonesia, 12(1), 67-79.
Supardi, S., Raharni, R., & Susyanty, A. L. (2022). Analisis kebijakan akses obat esensial di Indonesia: Tantangan dan strategi perbaikan. Buletin Penelitian Sistem Kesehatan, 25(3), 212-226.
Susanto, A., & Hartini, Y. (2023). Aplikasi machine learning dalam prediksi interaksi obat- protein: Pendekatan modern dalam penemuan obat. Pharmaceutical Sciences and Research, 10(1), 45-62.
WHO. (2023). Ending the neglect to attain the Sustainable Development Goals: A strategic framework for integrated control of neglected tropical diseases 2021-2030. Geneva: World Health Organization.
Widiastuti, E., & Pratama, M. R. (2023). Analisis proteomik komparatif pada pasien diabetes melitus tipe 2: Identifikasi biomarker spesifik populasi Indonesia. Indonesian Journal of Clinical Proteomics, 5(2), 78-93.
Yulianto, W., & Irawan, C. (2023). Kemajuan dalam desain dan pengembangan antibiotik baru untuk mengatasi resistensi antimikroba: Perspektif Indonesia. Acta Pharmaceutica Indonesia, 48(2), 103-121.
Zhang, H., Liu, T., Zhang, Z., et al. (2023). Integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell, 185(1), 200-223.e24.
Zulkarnain, A., & Martono, S. (2024). Pendekatan teranostik dalam pengembangan sistem penghantaran obat: Menuju era pengobatan presisi. Jurnal Ilmu Kefarmasian Indonesia,22(1),112-1
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Jurnal Ilmiah Kedokteran dan Kesehatan
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
